Delivery of drugs and biomolecules into skin has significant advantages. To achieve this, 50 herein, we report a nanomaterial strengthened dissolving microneedle patch for transdermal 51 delivery. The patch comprises thousands of microneedles which are composed of dissolving 52 polymers, nanomaterials and drug/biomolecules in their interior. With the addition of 53 nanomaterials, the mechanical property of generally weak dissolving polymers can be 54 dramatically improved without sacrificing dissolution rate within skin. In our experiments, as 55 a test case, we incorporated layered double hydroxides (LDH) nanoparticles into sodium 56 carboxymethylcellulose (CMC) to form a nanocomposite. The results show that, by adding 5 57 wt% of LDH nanoparticles into CMC, the elastic modulus of the polymer increases from 58 0.993±0.065 GPa to 2.878±0.123 GPa, which is comparable to that of engineering plastics 59 (e.g., 2.0-2.6 GPa for polycarbonate). Small and densely packed CMC-LDH microneedles 60 penetrate human and pig skin more reliably than pure CMC ones and attractively the 61 nanocomposite strengthened microneedles dissolve in skin and release payload within only 1 62
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ABSTRACT: 49
Delivery of drugs and biomolecules into skin has significant advantages. To achieve this, 50 herein, we report a nanomaterial strengthened dissolving microneedle patch for transdermal 51 delivery. The patch comprises thousands of microneedles which are composed of dissolving 52 polymers, nanomaterials and drug/biomolecules in their interior. With the addition of 53 nanomaterials, the mechanical property of generally weak dissolving polymers can be 54 dramatically improved without sacrificing dissolution rate within skin. In our experiments, as 55 a test case, we incorporated layered double hydroxides (LDH) nanoparticles into sodium 56 carboxymethylcellulose (CMC) to form a nanocomposite. The results show that, by adding 5 57 wt% of LDH nanoparticles into CMC, the elastic modulus of the polymer increases from 58 0.993±0.065 GPa to 2.878±0.123 GPa, which is comparable to that of engineering plastics 59 (e.g., 2.0-2.6 GPa for polycarbonate). Small and densely packed CMC-LDH microneedles 60 penetrate human and pig skin more reliably than pure CMC ones and attractively the 61 nanocomposite strengthened microneedles dissolve in skin and release payload within only 1 62
minute. Finally, we tested the application of using our nanocomposite strengthened 63 microneedle arrays for in vivo vaccine delivery and the results showed that significantly 64 stronger antibody response could be induced when compared with that generated by 65 subcutaneous injection. These data suggest that nanomaterials could be useful for fabricating 66 densely packed and small polymer microneedles that have robust mechanical properties and 67 rapid dissolution rate and therefore potential use in clinical applications. 68
Introduction 69
Microneedles are tiny projections of micrometer dimensions and have the capability of 70 delivering drugs and biomolecules to skin. [1] [2] [3] [4] [5] This transdermal delivery platform has many 71 advantages over conventional subcutaneous and intramuscular injection by needle and 72 syringe. First, there is no or minimal pain, cross-infection and needle stick injuries. [6] [7] [8] Second, microneedle can be designed to target specific layer of skin. Third, there is potential 74 for self-administration. Last but not least, it can be used when there is a significant first-pass 75 effect of the liver that can prematurely metabolize drugs. [9] Microneedle arrays are usually 76 made of silicon, metals and polymers. [10] Among them, polymer microneedle arrays are 77 increasingly attractive because they are expected to be less expensive to mass produce than 78 silicon or metal arrays and safer during application. Drugs and biomolecules can be 79 incorporated into the interior of microneedles themselves when using dissolving 80 polymers. [8, 11] During application, the polymer structure rapidly dissolves in skin, thereby 81 releasing the drug and biomolecules, so there is no sharp waste. 82
Despite their promising features, dissolvable polymers generally have very weak 83 mechanical properties. The need for combination of biocompatibility, robust mechanical 84 properties and rapid dissolution rate severely limits the choice of polymer. 85
Polyvinylpyrrolidone (PVP) [1, 8, 11] and carboxymethylcellulose sodium salt (CMC) [7, 12] are 86 commonly reported for making dissolving polymer microneedles. For example, PVP 87 microneedles were fabricated by either in-situ polymerization of monomers under UV 88 conditions (using a 100 W UV lamp) or heating at 80 C for 24 hours. [1, 8, 11] These harsh 89 conditions may seriously limit the incorporation of drug and biomolecules that are 90 temperature or UV sensitive. On the other hand, CMC microneedles can be fabricated at room 91 temperature, but CMC has weak mechanical properties. For example, the elastic modulus of 92 CMC is only around 1 GPa. [12] It is expected that the bioresorbable polymer microneedle size 93 needs to be relatively large to reliably pierce human skin. [12] This would apparently constrain 94 the density of microneedles on an array. However, recent study shows that small (base 95 diameter or width < 40 µm) and densely packed microneedles (over 10,000 microneedles per 96 cm 2 ) may lead to significantly enhanced vaccine efficacy when compared to large and 97 sparsely packed ones. [13, 14] In addition, small microneedles can be easily dried during fabrication and dissolve rapidly in skin during application. Therefore, improving the 99 mechanical properties of dissolving polymer microneedles could be beneficial in terms of 100 drug efficacy and design flexibility as well as ease in fabrication and rapid dissolution in the 101 skin. 102
To achieve this, we hypothesize that the use of reinforcing nanofillers will result in an 103 advanced biomedical material that can make enhanced dissolving polymer microneedles that 104 are mechanically more robust, while retaining the capacity to rapidly dissolve. Layered 105 double hydroxide (LDH) nanoparticles have been commonly used to reinforce a variety of 106 polymers. [15] For example, by adding only 1 wt% of LDH nanoparticles into nylon 6, the 107 elastic modulus of the composite increases 100% in comparison with that of pure nylon 6 108 polymer. [16] Therefore, in this paper, we have examined the potential for LDH nanoparticles 109 to enhance the mechanical strength of CMC cast in microneedle arrays for potential drug and 110 biomolecule delivery. We are the first to report the use of nanomaterials to improve the 111 mechanical characteristics of dissolving microneedle arrays for transdermal delivery. 112
Results 113

Characterization of Mg2Al-Cl-LDH Nanoparticles 114
We firstly prepared Mg2Al-Cl-LDH nanoparticles with a mean size of 80 nm and zeta 115 potential of +40 mV in aqueous and buffer-free solution (Figure 1a-c) . The as-prepared 116 aqueous suspension contained well suspended LDH nanoparticle without aggregation ( Figure  117 1a-b). XRD pattern shows the typical feature of Mg2Al-Cl-LDH nanoparticles (Figure 1d ). 118
Diffraction peaks shown in the XRD pattern of pristine LDH nanoparticles correspond to the 119 (003), (006) and (009) plane reflections of LDH.
We incorporated varying amounts of LDH into 2 wt% CMC aqueous solution to test the 122 strengthening effect of LDH nanoparticles on the mechanical properties of CMC. After the 123 samples were dried, nanoindentation was used to measure their elastic modulus and hardness. 124 loading-holding-unloading. Loading forces were increased at constant velocity and the 127 nanoindenter tip sank into materials during the loading period, which contributed to both 128 elastic and plastic deformation. Strong materials require a high force to achieve the same 129 penetration depth during the loading period. [16] As we can observe from Figure 2a , much 130 greater load is required for penetration of the same depth as LDH nanoparticle concentration 131 increases from 0 wt% to 2, 5 and 10 wt% (relative to the mass of CMC in the samples). 132
Apparently, adding LDH nanoparticles into CMC can significantly enhance its resistance to 133 indentation and make CMC-LDH composite much stronger than pure CMC. Figure 2b and 134 Figure 2c show the elastic modulus and hardness of polymers, respectively, calculated from 135 unloading. The elastic modulus of pure CMC is 0.993±0.065 GPa. The elastic modulus of 2 136 wt% of LDH loaded CMC increased to 1.489±0.036 GPa. With LDH concentration increased 137 to 5 wt%, the elastic modulus reaches 2.878±0.123 GPa. The elastic modulus increased to 138 290% of that of pure CMC polymer when 5 wt% of LDH nanoparticles were added to CMC 139 (p < 0.001). When the LDH concentration was increased to 10 wt%, the elastic modulus of 140 the nanocomposite started to decrease. It should be noted that the hardness of pure CMC 141 polymer is 0.067±0.001 GPa. The addition of LDH nanoparticles to CMC increased the 142 hardness of the composite material to 0.080±0.001 GPa, 0.111±0.004 GPa and 0.118±0.001 143
GPa for CMC composites with 2 wt%, 5 wt% and 10 wt% of LDH nanoparticles, 144
respectively.
Based on these results we chose the CMC composite with 5 wt% LDH nanoparticles as 146 the starting material for preparing microneedle arrays. Since centrifugation (3000 × g for 10 147 minutes) was used to force the viscous polymer solution to fill in the tiny cavity of a 148 microneedle PDMS mold, the concentration of CMC aqueous solution was increased to 5 149 wt% to avoid unequal LDH nanoparticle distribution within the centrifuged microneedles. 150
When 5 wt% LDH (relative to the mass of CMC) was added to the 5wt% CMC solution 151
followed by centrifugation at 4000 × g for 10 minutes, negligible amount of LDH 152 nanoparticles was sedimented by simply observing the mixture solution. The bottom layer of 153 the solution was discarded and supernatant was used for nanoindentation measurements. The 154 results show that the elastic modulus of 5 wt% CMC/5 wt% LDH was 2.486±0.186 GPa. The 155 value is slightly lower than the highest elastic modulus of the sample dried from the solution 156 of 2 wt% CMC incorporating with 5 wt% LDH, but it is still much better than that of pure 157 CMC (p < 0.001). The suspension of 5 wt% CMC/5 wt% LDH was then used for fabricating 158 microneedles. 159
Characterization of CMC-LDH Nanocomposite Microneedle Patches 160
The validation of the hypothesis that incorporation of LDH nanoparticles into CMC 161 could significantly increase the mechanical properties of the polymer supported the use of this 162 nanofiller-improved polymer to fabricate and test microneedle arrays. show typical SEM images of our dissolving polymer microneedles. The polymer 167 microneedles had uniform morphology and geometry. The microneedles were pyramidal in 168 shape and the tip radius is below 500 nm. The length of these fabricated polymer projections 169 is 165±3 µm (n=20 projections). This indicates a 24±1% reduction in length in comparison with that of the microneedles of the male mold. This decrease is mainly due to the contraction 171 and solidification of CMC based composite materials during drying. 172
Confocal Microscopy Study of the Penetration and Payload Delivery of 173
Nanocomposite Microneedle Patches in Human and Pig Skin 174
Once nanocomposite microneedle patches were successfully made, the next key 175 question was whether these microneedles can reliably penetrate stratum corneum and delivery 176 payload to skin? To perform this study, FITC-Dextran was simply mixed with CMC-LDH 177 nanoparticle solution as a viewable drug and biomolecule surrogate and then cast onto the tips 178
of microneedles and then we tested nanofiller composite microneedle penetration in excised 179 pig and human skin. To determine whether the microneedles can uniformly penetrate skin, For some delivery sites, it is obvious to see the holes created by the microneedle penetration. 204
The corresponding 3-D images (Figure 5b , 5d, 5f and 5h) clearly show that the FITC payload 205 was delivered vertically to certain depths beneath the skin surface. In a number of delivery 206 sites, it is even possible to see that the delivery payload started to diffuse a lot within the skin 207 after only 5 minutes. Collectively, Figure 5 demonstrates that the microneedles were capable 208 of piercing stratum corneum followed by dissolving in the skin and delivering the FITC 209 payload to the thin layer beneath the skin surface. 210
Now we have confirmed that the CMC-LDH nanocomposite microneedles can reliably 211 penetrate skin and deliver the payload into skin. Compared with CMC microneedles, the 212 nanomaterial strengthened microneedles result in more consistent penetration within the skin 213 cross the whole patch area. Another key question is whether these mechanically strengthened 214 microneedles can still rapidly dissolve in skin? To investigate this, we observed the 215 microneedles before application in skin and at 1, 2 and 5 minutes after skin penetration. The 216 results are shown in Figure 6 . The figure shows the merged fluorescence and reflectance 217 confocal microscopy images of microneedles before and after being applied to skin. Before 218 application, the fluorescent payload can be clearly seen in green throughout the shaft of the 219 microneedles ( Figure 6a ). No fluorescence signal could be detected at the base of the array, which has the added benefit of reducing cost through conserving drug molecules to the 221 microneedles only and therefore reducing drug wastage during delivery. Because of this, in 222 our experiments, minimal fluorescence was seen on the surface between the microneedles due 223 to the payload being cast within the projections instead of 'wasted' in the backing layer of the 224 microneedles. After skin application, it can be seen that almost all of the microneedles are 225 dissolved in the skin after only 1 minute. 226
In vivo Delivery of Antigen to Skin and Successful Immunization of Mice 227
Having confirmed that our nanocomposite microneedles can robustly penetrate, quickly 228 deliver payload to human and pig skin and target specific skin layers, next we test the 229 application of the nanocomposite microneedle arrays for vaccine delivery. We fabricated 230 CMC and CMC-LDH microneedle arrays with 10 and 1.65 µg of ovalbumin (OVA) protein, 231 respectively. Pure CMC polymer microneedle arrays were used as a control in the experiment. 232
Mice were anesthetized and a single microneedle patch was applied to each ear, therefore 2 233 microneedle patches were used for each mouse. As a positive control, we subcutaneously 234 injected 20µg of OVA protein to mice. The induced antibody titers of mice are shown in 235 Figure 7a . The antibody titers between the two microneedle 240 immunized groups do not show statistical difference (p > 0.1). If we compare the standard 241 error of the mean of the two microneedle groups, it is easy to find that the antibody titers 242 generated by CMC-LDH microneedle patch vaccination are more consistent than those 243 induced by CMC microneedle immunization.
The mice were then boosted at 17 days after primary immunization and sera were 245 collected at 21 days after the boost (38 days after primary vaccination). From Figure 7b , it can 246 be seen that, after boost, SC injection of 20 µg of OVA protein led to reasonably high 247 antibody titers, although still much lower than those induced by microneedle vaccination (p < 248 0.001). The other finding is that, after boost, CMC-LDH microneedle arrays containing 3.3 µg 249 of OVA protein led to stronger immune response than that induced by pure CMC microneedle 250 patches with 20 µg of OVA protein (p < 0.001). 251
Discussion 252
In this paper, we hypothesized that the LDH nanoparticles could enhance the 253 mechanical properties of CMC microneedles and thereby improve transdermal delivery. We 254 chose CMC because it had often been used as a material in dissolving microneedles [7, 12] in the 255 literature, but the elastic modulus of CMC is only 1 GPa [12] , which potentially limits the 256 successful application of CMC microneedles in transdermal drug and biomolecule delivery 257 for humans, particularly when one needs to fabricate densely packed microneedles for certain 258 needs. LDH nanoparticles were selected to increase the mechanical strength of CMC because 259 of their high biocompatibility, high aspect ratio (lateral size over thickness), low cost and 260 previous use in enhancing mechanical strength in polymers. [15] [16] [17] Furthermore, CMC is 261 negatively charged in solution and may well be incorporated into the internal layers of LDH 262 nanoparticles and help disperse LDH nanoparticles uniformly. Consistent dispersion is a 263 crucial challenge when formulating nanofillers to mechanically strengthen polymers as better 264 dispersion of nanomaterials/fillers leads to enhanced mechanical properties. [15] The 265 mechanical strength of CMC was greatly enhanced by adding LDH nanoparticles. The elastic 266 modulus of our CMC-LDH composite microneedles is comparable to that of engineering 267 plastics, e.g. 2-4 GPa for nylon and 2.0-2.6 GPa for polycarbonate. This improvement has the 268 capacity to increase the flexibility of drug and molecule formulations that can be incorporated into dissolving microneedle arrays. It is expected that the addition of drug and molecules, 270 composed primarily of proteins and salts, will worsen the mechanical properties of the 271 structural polymer in a concentration dependent manner. The addition of reinforcing 272 nanofillers could help to curb that effect such that the final microneedle array remains useful 273 for animal and human applications. 274
Our fabrication process was operated at room temperature (23 C). Lowering the 275 temperature to optimize the stability of the drugs and molecules could be explored using this 276 casting technique. The entire fabrication process required no heating, UV illumination or any 277 other harsh conditions or treatments and therefore our technique is suitable for incorporating 278 delicate drugs and biomolecules into microneedles for subsequent transdermal delivery. The 279 enhanced mechanical properties of the CMC-LDH composite microneedles successfully 280 pierced pig and human skin to deliver a FITC-labeled dextran payload. Importantly, the 281 nanoparticle strengthened polymer microneedles retained the capacity to dissolve quickly, 282 within only 1 minute. Quick dissolution within skin is crucial for a short administration time. 283
For comparison, in a previous report, methacrylic acid (MAA) was copolymerized with vinyl 284 pyrollidone (VP) to form poly(vinylpyrrolidone-co-methacrylic acid) (PVP-MAA) to improve 285 the mechanical strength of the fabricated microneedles. However, with the addition of MAA, 286 the dissolution rate of the microneedles greatly slowed. For example, PVP-MAA 287 microneedles (25% MAA) need 2 hours to dissolve within porcine skin while at the same size 288 pure PVP microneedles dissolve within 15 minutes. [8] 289
Skin contains abundant of immune cells and the density of these cells is much high than 290
that in subcutaneous tissue and muscle to which vaccines are usually delivered by needle and 291 syringe injection. Therefore, if we can deliver vaccines to the skin layers, their efficacy should 292 be greatly enhanced. Although it is possible to use conventional needle and syringe to achieve 293 intradermal injection for delivering vaccine to the skin, it is technically challenge to perform because the skin is very thin. To achieve reliable skin delivery, many approaches such as 295 liquid jet injection, biolistic microparticle injection, thermal or laser assisted delivery and 296 microneedles have been developed. [18] When these approaches were tested for vaccine 297 delivery to skin and compared with conventional intramuscular (IM) or SC injection, it was 298 found that the vaccine efficacy was dramatically improved. [19] [20] [21] [22] To test whether our 299 nanocomposite strengthened microneedle arrays can pierce skin and deliver payload to the 300 targeted skin layers, we investigated the penetration and payload delivery by RCM and 301 LSCM. The results confirmed that the composite microneedles successfully penetrated 302 stratum corneum and delivered the FITC-labeled dextran payload up to around 64±9 µm 303 below the human skin surface. The human epidermis layer contains high density of APCs and 304 its thickness, using human forearm dorsal epidermis as an example, is 61.3±11.0 m. [23] This 305 means that most of the payload was delivered within the target layer. 306
Once demonstrating that the nanocomposite strengthened microneedle arrays could 307 deliver payload to skin, next key question will be whether they can induce robust immune 308 response. To investigate this, we loaded OVA protein in the microneedle arrays and 309 performed immunization trial in mouse model. The results suggested that dissolvable pure 310 CMC microneedle patches could induce much stronger immune response when compared 311 with conventional efficient SC injection (generally more efficient than the commonly used 312 intramuscular injection). Attractively, it was confirmed that the nanocomposite strengthened 313 microneedle arrays worked even better than the pure dissolvable ones. This is in line with the 314 findings from the penetration experiments. Because nanocomposite strengthened microneedle 315 arrays could penetrate skin better and worked more reliably, it was apparent that the 316 strengthened arrays should deliver more vaccine dose into skin. In other words, 317 nanocomposite strengthened microneedle arrays were capable of increasing vaccine delivery 318 efficiency.
Moreover, LDH nanoparticles have been widely used for efficient delivery of a range of 320 drugs such as anticancer drug methotrexate (MTX), [24, 25] low molecular weight heparin 321 (LMWH), [26] siRNA [27] [28] [29] and plasmid DNA. [30, 31] The biocompatibility and safety profiles 322 obtained these studies will certainly help the potential use of LDH nanoparticles in our 323 nanocomposite microneedle arrays in future clinical applications. In the meantime, it also 324 opens the opportunity of incorporating vaccine into LDH nanoparticles for transdermal 325 nanovaccine delivery. This will be very suitable for DNA and siRNA delivery because these 326 molecules need to enter cells to be functional and their existence in nanovaccine form will 327 greatly increase their intracellular delivery. In this case, LDH nanoparticles will play 328 multifunctional roles including mechanical strengthening and nanovaccine carrier. 329
Conclusion 330
In this study, we demonstrated that LDH nanoparticles can reinforce dissolving polymer 331 microneedles. By adding 5 wt% of LDH into CMC, the elastic modulus increases from 332 0.993±0.065 GPa to a maximum of 2.878±0.123 GPa (p < 0.001). Additionally, we 333 successfully manufactured LDH nanoparticle-reinforced, dissolving polymer microneedles 334 with uniform shape and size. The polymer microneedles have an extremely sharp tip with an 335 average radius below 500 nm. The fabrication process was conducted at room temperature 336 without the need for any harsh conditions that may degrade drugs and biomolecules. Confocal 337 microscopy results confirmed that the nanofiller strengthened the dissolving microneedles by 338 improving their mechanical properties to allow the microneedles to reliably pierce into pig 339 and human skin, while pure CMC polymer microneedle were more likely to bend on the 340 surface of skin. The composite microneedles retained the capacity to dissolve rapidly in skin 341 within only 1 minute and released the incorporated payload. The payload distribution was 342 highly localized within the skin. Finally, we tested the application of using our nanocomposite 343 strengthened microneedle arrays for vaccine delivery and the results showed that significantly stronger antibody response could be induced when compared with subcutaneous injection. 345
Overall, this represents an important step toward dissolving microneedles that have robust 346 mechanical properties with potential use in clinical applications. 347
Experimental Section 348
Preparation of Mg2Al-LDH Nanoparticles: Mg2Al-LDH nanoparticles were prepared 349 according to the method described by Xu et al. [32, 33] Briefly, 10 ml of LDH solutions with different concentrations were mixed with 200 mg of 360 CMC to prepare composite solution followed by placing in fume hood and drying to obtain 361 polymer nanocomposite. The prepared nanocomposites contained 2 wt%, 5 wt% and 10 wt% 362 LDH nanoparticles. The weight percentage is the mass ratio of LDH nanoparticles to CMC. 363
During microneedle fabrication, CMC-LDH solution was centrifuged onto the mold at a 364 speed of 3000 × g for 10 minutes. To mimic this process, for another batch of samples, 10 ml 365 of solution containing 25mg LDH nanoparticles was mixed with 500 mg of CMC and the 366 mixture was sonicated for 30 minutes. After that, the solution was centrifuged for 10 min at 367 4000 × g. The amount of the nanoparticles which were centrifuged to the bottom of solution 368 was trivial. The upper layer of solution was collected and sonicated for 30 minutes for being 369 used to make nanoindentation samples and microneedle arrays. 370
Fabrication of Dissolving Polymer Microneedle Patches: Silicon microneedle arrays 371
were used as male mold. The arrays were fabricated according to methods described in 372 literature. [34] Briefly, a slicon wafer was diced by a diamond blade to create silicon 373 microcolumns of required dimension and spacing. A two-step isotropic etching using a 374 mixture of nitric acid and hydrofluoric acid was used to fabricate sharp microneedles. This 375 silicon microneedle array male mold was washed with ethanol for 3 times and dried in air and 376 then PDMS was slowly poured over the surface of silicon microneedle array. The silicon 377 microneedle array male mold immersed in PDMS was placed in a fume hood for curing for 24 378 hours. After curing, the silicon microneedle array male mold was peeled off and the PDMS 379 female mold was washed with water and ethanol for 3 times before casting. Figure 8 shows 380 the steps to manufacture a dissolving polymer microneedle patch. and human) was stored at -20 o C prior to use. For microneedle application, the skin (pig or 406 human) was thawed, rinsed, dried then pinned down taut on a covered corkboard. The tissue 407 was stored on saline moistened gauze throughout the experiment when not in use. A 408 microneedle array was then applied using a spring applicator for 1, 2 or 5 minutes (n = 3 per 409 skin type). After microneedle application, the treatment area was excised with an 8 mm 410 biopsy and the tissue fixed in 1 mL 4% formaldehyde in methanol for 1 hour. Following 411 fixing, the tissue was removed and washed 3 times for 10 minutes in 1 mL 0.1M phosphate 412 buffered saline. The samples were then stored at 4 o C until imaging. 413
Confocal Microscopy Observation of Skin after Patch Application: Reflectance confocal 414 microscopy was done using a Vivascope® 1500 Multilaser (Lucid Inc., Rochester, NY, 415 U.S.A). The protocol was adapted from a previously published procedure. [35] Briefly, a laser diode was used to excite the tissue at 830 nm. ImageJ (NIH, U.S.A) was used to analyse the 417 images. Laser scanning confocal microscopy was done using a Zeiss LSM 510 Meta (Carl 418 Zeiss Inc., Germany). Prior to imaging the tissue was stained with Hoechst 33342, a nuclei 419 stain. A stock solution of 10 mg/mL Hoechst 33342 in dimethyl sulfoxide was prepared. A 420 working solution was made by a 1:1000 dilution in 0.1 M phosphate buffered saline. The 421 tissue was incubated with the stain for 1 hour at room temperature followed by three washing 422 steps for 10 minutes in 0.1 M phosphate buffered saline. The wavelengths used to excite the 423 FITC-dextran and Hoechst 33342 was 488 nm and 405 nm, respectively. 424
Vaccination of OVA protein vaccine: Three groups of C57BL/6 female mice were 425 vaccinated with OVA protein either by SC injection using needle and syringe (5 mice in the 426 group), or microneedle array application (4 mice per group). Another group of four untreated 427 mice were used as negative control. For SC injection, saline solution with 20 µg OVA protein 428 was injected to each mouse. For microneedle array vaccination, one patch was applied to one 429 ear of a mouse (total 2 patches for each mouse). The patches were applied to mice skin by a 430 spring applicator and kept in place for 2 minutes. At 14 days after primary immunization, sera 431 were collected. A boost vaccination was given at 17 days post primary vaccination and sera 432 were collected at 21 days after the boost. 433 ELISA protocol: ELISA was performed as previously described. [36] Briefly, ELISA plates 434 (Corning) were coated with 50 µg mL -1 of ovalbumin (Acros) in 0.1M of sodium bicarbonate 435 buffer (Sigma) overnight at 4 o C. These coated plates were used to measure the titers of 436 specific IgG induced. Color development was carried out using ABTS (diammonium 2,2-437 azino-bis(3-ethylbenzothiazoline-6-sulfonate; Sigma) as the substrate. The absorbance 438 readings at 405 nm were then measured against control wells containing no antiserum in the 439 reaction. 
